---
title: "Measuring Health and Disease in Populations (chapter 2)"
subtitle: "Eric Delmelle <br> Jan 29 - Feb 5 - Feb 10 - Feb 17, 2025"
format: revealjs
---

```{=html}
<style>
ul {
  font-size: 85%;
}

ul ul {
  font-size: 75%;
}
</style>
```
## [**Introduction**]{style="color: teal;"}

### [**Key Concepts in Measuring Health and Disease**]{style="color: pink;"}

-   Definitions of incidence and prevalence.
-   Importance of population health metrics.
-   Ageing in the population
-   Demographic transition
-   Life table and life expectancy
-   The importance to standardize

------------------------------------------------------------------------

## [**Incidence and Prevalence**]{style="color: teal;"}

### [**Definitions**]{style="color: pink;"}

-   **Incidence:** Number of new cases in a specified time period.
    -   Formula: `(New cases during time period / Population at risk) × multiplier`.
-   **Prevalence:** Total number of existing cases at a given time.
    -   Formula: `(Existing cases / Total population) × multiplier`.

### [**Differences**]{style="color: pink;"}

-   Incidence: Measures risk; useful for studying causation.
-   Prevalence: Measures disease burden; important for planning healthcare services.

------------------------------------------------------------------------

## [**Impact of New and Existing Cases**]{style="color: teal;"}

-   **Prevalence Formula Relation:**
    -   `Prevalence = Incidence × Duration of Disease`
    -   check this [youTube](https://s4be.cochrane.org/blog/2020/11/06/prevalence-vs-incidence-what-is-the-difference/){.uri} video
-   **Factors affecting prevalence:**
    -   **Increase:** Longer disease duration, improved survival without a cure.
    -   **Decrease:** Shorter duration, high mortality rates, or prevention.

------------------------------------------------------------------------

## [**Rates, Ratios, and Proportions**]{style="color: teal;"}

-   **Rate:** A measure of change per unit time (e.g., incidence density).
    -   *pay attention to **rate instability***
-   **Ratio:** Comparison of two numbers, unrelated (e.g., sex ratio).
-   **Proportion:** A part of a whole (e.g., percentage of women in a study group).

------------------------------------------------------------------------

## [**Cumulative incidence**]{style="color: teal;"}

-   **Proportion** of an initially disease-free group of individuals who develop the disease within a specified period of observation.

    -   *pay attention to **censoring*** $$ CI = \frac{\text{new cases}}{\text{# individuals at start of the period}} $$

-   Example: Start with **100 disease-free individuals**. After **one year, 10 develop the disease**.

    $$ CI = \frac{10}{100} = 0.10$$

-   After **one year**, **10% of the population developed the disease**.

------------------------------------------------------------------------

## [**Incidence density**]{style="color: teal;"}

-   **Rate** that measures how often new cases of a disease occur while accounting for different lengths of time that people are at risk $$ ID = \frac{\text{new cases}}{\text{total person-time at risk}}$$

-   Study follows **5 individuals**:

    -   **Person A:** 2 years at risk\
    -   **Person B:** 3 years at risk\
    -   **Person C:** 1 year at risk\
    -   **Person D:** 4 years at risk\
    -   **Person E:** 2 years at risk

-   **Total person-time at risk** = **2 + 3 + 1 + 4 + 2 = 12 person-years**

------------------------------------------------------------------------

## [**Incidence density**]{style="color: teal;"}

-   **Total person-time at risk** = **2 + 3 + 1 + 4 + 2 = 12 person-years**
-   **New cases = 3**

$$ ID = \frac{3}{12} = 0.25 \text{ cases per person-year} $$

-   **0.25 cases per person-year** means that, on average, for every 4 people followed for a year, 1 will develop the disease.

------------------------------------------------------------------------

## [**Demographic Changes and Health Metrics**]{style="color: teal;"}

-   **Fertility Rate:** Key measure of reproductive behavior.
-   **Mortality:** Affects life expectancy and health metrics.
-   **Migration:** Alters population composition, health service demands.

------------------------------------------------------------------------

## [**Population Structure**]{style="color: teal;"}

### [**Age Pyramids**]{style="color: pink;"}

-   Graphical representation of age and sex distribution.
-   Shows aging trends, and reveals impact of demographic events like wars, migrations.

![](imgs/Dtm_pyramids.jpg){fig-align="center"}

------------------------------------------------------------------------

### [**Age Pyramids**]{style="color: pink;"}

![](imgs/Dtm_pyramids.jpg){fig-align="center"}

-   **Developed Countries:** Narrow base, wider top (aging population).
-   **Developing Countries:** Broad base, narrow top (younger population).
-   [Interactive](https://www.populationpyramid.net/){.uri} pyramid.

------------------------------------------------------------------------

### [**Qatar Age Pyramid**]{style="color: pink;"}

::: columns
::: {.column width="60%"}
![](imgs/qatarPyramid.jpg){fig-align="center" width="100%"}
:::

::: {.column width="40%"}
![](imgs/qatarQR.jpg){fig-align="center" width="100%"}
:::
:::

------------------------------------------------------------------------

## [**Interactive Activity**]{style="color: teal;"}

::: columns
::: {.column width="45%" style="font-size: 18px; line-height: 1.2;"}
-   **Group A**: Kayla H., Sammie C., Chloe L., Henry S., Vedanth V.\
-   **Group B**: Prashant K., Lillian L., Ashley P., Cate M., Emily T.\
-   **Group C**: Shriya P., Evy W., Caithlyn C., Grace S.\
-   **Group D**: Chris C., Olivia N., Aaron C., Lola S., Alicia A.\
-   **Group E**: Elmira S., Sebastian S., Mina C., Hudson K., Marwa A.\
-   **Group F**: Abena A., Xiomara G., Natalie W., Neves H.\
-   **Group G**: Sophie P., Jessica L.,Joy L., Vladimir V.
:::

::: {.column width="55%" style="font-size: 30px; line-height: 1.4;"}
### Analysis Instructions

-   Choose an age pyramid.
-   Explain to class what you see and what you expect the population to look like in 15, 30 and 50 years.
:::
:::

------------------------------------------------------------------------

## [**Demographic Transition**]{style="color: teal;"}

-   4 stages of transitions
-   There is actually a fifth stage

![](imgs/demographicTransition.jpg){fig-align="center" width="800"}

------------------------------------------------------------------------

## [**Demographic Transition**]{style="color: teal;"}

-   **Stage 1**: high burden of infectious diseases, high maternal/child mortality
-   **Stages 2 & 3**: transition to chronic diseases; improved health infrastructure
-   **Stages 4 and 5**: dominance of Non-Communicable Diseases (NCDs), and ageing related conditions

------------------------------------------------------------------------

## [**Preston Curve**]{style="color: teal;"}

### [**GDP vs. Life Expectancy**]{style="color: pink;"}

-   How do country's economic status and life expectancy relate?
    -   Higher GDP often correlates with longer life expectancy.
    -   Plateau effect beyond a certain GDP.

![](imgs/prestonA.jpg){fig-align="center"}

------------------------------------------------------------------------

## [**Preston Curve**]{style="color: teal;"}

-   **A**: the new technology is equally applicable in all countries regardless of their level of income.
-   **B**: the new technology has a disproportionately larger effect in rich countries.
-   **C**: poorer countries benefit more.

![](imgs/prestonB.jpg){fig-align="center"}

------------------------------------------------------------------------

## [**Aging Populations**]{style="color: teal;"}

-   **Trends:**
    -   Increasing proportion of elderly.
    -   Dependency ratios rise, impacting economic and health systems.

![](imgs/life-expectancy-cumulative-over-200-years.png){fig-align="center"}

------------------------------------------------------------------------

## [**Aging Populations**]{style="color: teal;"}

![](imgs/percentSurviving.jpg){fig-align="center"}

------------------------------------------------------------------------

## [**Aging Populations**]{style="color: teal;"}

![](imgs/percentSurvivingB.jpg)

------------------------------------------------------------------------

## [**Rectangularization of Life Expectancy**]{style="color: teal;"}

-   Survival curves become more rectangular as mortality compresses toward older ages.
-   **Implications:**
    -   Shift to chronic diseases as leading health concerns.
    -   Need for age-specific interventions.

------------------------------------------------------------------------

### [**Survival curves in Sweden**]{style="color: pink;"}

![](imgs/survivalSweden.png){fig-align="center" width="510"}

[Source: Schoder, J., & Zweifel, P. (2011). Flat-of-the-curve medicine: a new perspective on the production of health. Health Economics Review, 1, 1-10.]{style="font-size: 0.6em;"}

------------------------------------------------------------------------

### [**Survival curves in USA**]{style="color: pink;"}

![](imgs/survivalUSA.png){fig-align="center" width="503"}

[Source: Bell, F. C., & Miller, M. L. (2005). Life tables for the United States social security area, 1900-2100 (No. 120). Social Security Administration, Office of the Chief Actuary.]{style="font-size: 0.6em;"}

------------------------------------------------------------------------

# Mortality Metrics

## Crude Death Rate (CDR)
- Number of deaths per 1,000 individuals per year.
- Can be refined by breaking it down by age, sex, and socioeconomic status.
- **Example:** CDR in Mexico < CDR in the USA, but age distribution must be considered.

## Case Fatality Rate (CFR)
- Proportion of individuals with a disease who die from it.
- Indicates severity and lethality of a disease.
- **Example Calculation:** CFR = (Disease deaths / Total diagnosed cases) × 100

------------------------------------------------------------------------

## Standardized Mortality Ratio (SMR)
- Adjusts mortality rates for different population age structures.
- **Formula:** SMR = (Observed Deaths / Expected Deaths) × 100
- **Example Calculation:**
  - Observed deaths: 93
  - Expected deaths: 70.5
  - SMR = (93 / 70.5) × 100 = **132** (indicating 32% higher mortality than expected)

------------------------------------------------------------------------

# Life Table Construction

## Steps in Constructing a Life Table (1)

:::::: {.columns}
::: {.column width="45%" style="font-size: 22px; line-height: 1.2;"}

#### Define Age Groups{style="color: blue;"}
- 0-20, 21-40, 41-60, 61+
<br><br><br>

#### Initialize Population (l₀){style="color: blue;"}
- Assume l₀ = 100,000
<br><br><br>

#### Define Mortality Rates (qₓ){style="color: blue;"}
- 0-20: qₓ = 0.005
- 21-40: qₓ = 0.01
- 41-60: qₓ = 0.15
- 61+: qₓ = 0.50

:::
::: {.column width="45%" style="font-size: 22px; line-height: 1.2;"}

#### Calculate Deaths (dₓ){style="color: blue;"}

$$ dₓ = lₓ \times qₓ $$
- **Example:** $$ d_{0-20} = 100,000 \times 0.005 = 500 $$

#### Calculate Survivors (lₓ){style="color: blue;"}

-   $lₓ$ for next group = previous $lₓ - dₓ$
-   **Example:** $$ l_{21-40} = 100,000 - 500 = 99,500 $$
:::
::::::

------------------------------------------------------------------------

## Steps in Constructing a Life Table (2)

:::::: {.columns}
::: {.column width="45%" style="font-size: 22px; line-height: 1.2;"}


#### Calculate Person-Years Lived (Lₓ){style="color: blue;"}
- $Lₓ = \frac{lₓ + l_{x+1}}{2} \times n$
- Example: $L_{0-20} = \frac{100,000 + 99,500}{2} \times 20 = 1995000$
   
   
#### Calculate Total Years Remaining (Tₓ){style="color: blue;"}
- $Tₓ$= Sum of all subsequent $Lₓ$ values.

#### Derive Life Expectancy (eₓ){style="color: blue;"}
- $eₓ = \frac{Tₓ}{lₓ}$
- Represents average remaining years of life for individuals entering each age group.
:::
::: {.column width="45%" style="font-size: 22px; line-height: 1.2;"}

```{r}
library(knitr)
life_table <- data.frame(
  Age_Group = c("0-20", "21-40", "41-60", "61+"),
  Initial_Population = c(100000, 99500, 98550, 83767),
  Mortality_Rate = c(0.005, 0.01, 0.15, 0.50),
  Deaths = c(500, 995, 14783, 41883),
  Survivors = c(99500, 98550, 83767, 41884),
  Person_Years = c(1995000, 1980500, 1823170, 1256510),
  Total_Years_Remaining = c(7055180, 5060180, 3079680, 1256510),
  Life_Expectancy = c(70.55, 50.85, 31.25, 15.00)
)
kable(life_table)
```


:::
::::::


------------------------------------------------------------------------

# Years of Life Lost 
- Years of Life Lost (YLL) quantifies the impact of premature mortality in a population.
- Used in public health to evaluate disease burden and prioritize interventions.

------------------------------------------------------------------------

## Methodology for Calculating YLL{style="color: teal;"}

#### Definition of Premature Mortality Age{style="color: blue;"}
- Premature mortality is defined relative to a threshold age, typically the average life expectancy.
- For this example, we use **75 years**.

#### Identification of Age at Death{style="color: blue;"}
- Essential for determining premature deaths.
- Each death’s impact varies depending on age at death.

------------------------------------------------------------------------

#### Calculation of Individual YLL{style="color: blue;"}
- Formula:
  $\text{YLL} = T - a_i$
  where:
  - $T$ is the threshold age,
  - $a_i$ is the individual's age at death.

#### Summation of YLL{style="color: blue;"}
- Total population impact calculated as:
  $\text{Total YLL} = \sum \text{YLL}_i$

------------------------------------------------------------------------

### Example Calculation{style="color: pink;"}

Consider three individuals dying at **ages 25, 35, and 60**, with a threshold of **75 years**:

:::::: {.columns}
::: {.column width="45%"}
- **Individual 1:**
  - Age at death: 25
  - YLL = 75 - 25 = **50 years**
- **Individual 2:**
  - Age at death: 35
  - YLL = 75 - 35 = **40 years**
:::

::: {.column width="45%"}
- **Individual 3:**
  - Age at death: 60
  - YLL = 75 - 60 = **15 years**

- **Total YLL:**
  $50 + 40 + 15 = 105 \text{ years}$
  
:::
::::::

------------------------------------------------------------------------

### Discussion{style="color: teal;"}

- The **105 years of YLL** highlight the burden of premature deaths.
- Helps health authorities prioritize interventions.
- Modifications include:
  - Discounting future years,
  - Weighting younger deaths more heavily,
  - Adjusting for epidemiological and demographic context.
- *Let's look at Box 2.5 in the book*.



------------------------------------------------------------------------

### Summary{style="color: teal;"}

- Crude Death Rate (CDR) and Case Fatality Rate (CFR) provide baseline mortality measures.
- Standardized Mortality Ratio (SMR) adjusts for age distribution differences.
- Life tables are constructed step-by-step to estimate life expectancy at various ages.
- **Years of Life Lost (YLL)** quantifies premature mortality and is crucial for measuring disease burden.
- YLL helps prioritize public health interventions by identifying the most significant sources of early death.


------------------------------------------------------------------------

## [**Fertility**]{style="color: teal;"}

-   **Some definitions**
    -   *crude birth rate (CBR)*: number of births per 1,000 population per year. The denominator, however, refers to the total population, including men and boys, young girls and old women!
    -   *general fertility rate (GFR)*: restricts inclusion in its denominator only to women in the reproductive age range
    -   *total fertility rate (TFR)*: summing all age-specific fertility rates for women in the childbearing ages.

------------------------------------------------------------------------

### [**Birth rates in US, Canada, Mexico**]{style="color: pink;"}

![](imgs/birthRate.jpg){fig-align="center"}

------------------------------------------------------------------------

### [**Deriving Total Fertility Rate**]{style="color: pink;"}

::: columns
::: {.column width="40%"}
#### Age-Specific Fertility Rates (ASFRs) for the U.S. (2000)

<small> - **15--19**: 48.5/1,000\
- **20--24**: 112.3/1,000\
- **25--29**: 121.4/1,000\
- **30--34**: 94.1/1,000\
- **35--39**: 40.4/1,000\
- **40--44**: 7.9/1,000\
- **45--49**: 0.5/1,000

**Total:** 425/1,000\
</small>
:::

::: {.column width="60%"}
#### Explanation

[- The ASFR represents the birth rate per 1,000 women in each age group.\
- Summing the ASFRs gives **425/1,000** for all age groups. - <br>Since each ASFR represents a **five-year** average, multiplying by 5 gives **2,125/1,000**. This means the **TFR = 2.1 births per woman**, the replacement-level fertility rate typical of developed countries. Including **ages 10--14 or 50--54** has little impact on the overall TFR.]{style="font-size: 70%"}
:::
:::

------------------------------------------------------------------------

## [**Aging Populations**]{style="color: teal;"}

-   **Policy Implications:**
    -   Need for long-term care services.
    -   Redesign of healthcare systems.


------------------------------------------------------------------------



## [**Book exercise**]{style="color: teal;"}

::: columns

::: {.column width="50%"}

### <small>**Exercise 2.1: State of the Population**</small>

<small>
In the 2000 census, the total population of the United States was 281,423,000, with the following age-sex distribution (rounded to the nearest thousand):

| Age Group | Male Population | Female Population | Total Population |
|-----------|---------------|----------------|----------------|
| 0–1       | 1,949,000      | 1,857,000       | 3,806,000       |
| 1–4       | 7,862,000      | 7,508,000       | 15,370,000      |
| 5–14      | 21,044,000     | 20,034,000      | 41,078,000      |
| 15–44     | 62,647,000     | 61,577,000      | 124,224,000     |
| 45–64     | 30,143,000     | 31,810,000      | 61,953,000      |
| 65+       | 14,410,000     | 20,582,000      | 34,992,000      |
| **Total** | **138,055,000** | **143,368,000** | **281,423,000** |
</small>

:::

::: {.column width="50%"}

### <small>**Calculations**</small>
<small>

- (a) **Proportion of the Elderly (65+ years) in the Population**  

- (b) **Proportion of the Young (0–14 years) in the Population**  

- (c) **Sex Ratio in Age Group 0–14 (expressed as 100 males per females)**  

- (d) **Sex Ratio in Age Group 65+ (expressed as males per 100 females)**  

</small>

:::

:::
------------------------------------------------------------------------

## [**At home exercise**]{style="color: teal;"}

<small>

-   Analyze an example population pyramid.
-   Predict changes over 20 years based on fertility and mortality trends.
-   [fertility trend and mortality](https://data.worldbank.org/indicator/SP.DYN.TFRT.IN){.uri}


$$
P(t) = P_0 \times \left(1 + \frac{B - D}{1000} \right)^t
$$ 


-   $P(t)$: The **population** at time $t$, after $t$ years.
-   $P_0$: The **current population** (the population at time $t = 0$).
-   $B$: The **birth rate**, expressed as the number of **births per 1,000 people** per year.
-   $D$: The **death rate**, expressed as the number of **deaths per 1,000 people** per year.
-   $t$: The **number of years** into the future you are projecting (e.g., 20 years).

</small>

------------------------------------------------------------------------

## [**Summary**]{style="color: teal;"}

### [**Key Takeaways**]{style="color: pink;"}

-   Differences between incidence and prevalence.
-   Importance of understanding demographic changes.
-   Using tools like age pyramids to predict health trends.

### [**Discussion Questions**]{style="color: pink;"}

-   How do changes in prevalence reflect healthcare advances?
-   What policies can address the challenges of aging populations?

------------------------------------------------------------------------

## [**References**]{style="color: teal;"}

1. Young, T. K. (2004). *Population Health: Concepts and Methods.*
2. WHO Reports on Health Metrics.
3. National Center for Health Statistics.
4. Preston, S. H. (1975). *The changing relation between mortality and level of economic development.* Population Studies, 29(2), 231-248.
5. Omran, A. R. (1971). *The Epidemiologic Transition: A Theory of the Epidemiology of Population Change.* The Milbank Quarterly, 49(4), 509–38.

